HEALTH CARE
Recent and archived news stories on: biotechnology, pharmaceutical companies, health insurance companies, hospitals, medical devices, medical groups
Puma Shares Slip as Sales of Cancer Drug Fall
Shares of Pasadena-based Puma Biotechnology Inc. fell after the company revealed that sales of its breast cancer treatment drug, Nerlynx, declined during the fourth quarter.
Herbalife Sees Coronavirus Impact
Company anticipates disruption in operations for quarter, year
Count downtown-based nutrition supplement company Herbalife Nutrition Ltd. as another company feeling the impact of the rapid spread of the Covid-19 coronavirus throughout China.
OC’s Hoag Moves Into LA County
Institute acquires surgery center in Marina del Rey
Hoag Memorial Hospital Presbyterian, one of Orange County’s largest hospital and health care networks, is entering the Los Angeles County market.
ChromaDex Expands Pact
Nestlé service will boost company’s supplement
The world’s largest food and beverage company has agreed to flex more of its marketing muscle for a product from Westwood-based nutrition company ChromaDex Inc.
FDA Gives Kite Cellular Drug Therapy Fast Track Designation
The FDA must decide within six months whether to approve the drug, known as KTE-X19
Xencor to License Food Allergy Drug
Deal with Aimmune could bring up to $400 million before royalties
Monrovia-based biopharmaceutical company Xencor Inc. announced it has granted a license to Bay Area-based Aimmune Therapeutics Inc.
Molina Expects Positive Results Ahead
Managed care insurer projects $17 billion in revenue for 2020
With the release of fourth-quarter and full-year 2019 earnings, Molina issued a forecast of premium revenue growth for this year of 7.4% to about $17.4 billion.
Puma Shares Soar 81% Over 2 Days
Biotechnology company stays quiet amid speculation about run-up
After a year of lackluster and disappointing performance, shares of Westwood-based biopharmaceutical company Puma Biotechnology Inc. mysteriously shot up 81% Feb. 4 and 5 on some of its heaviest trading volume in years.
Arrowhead announces 'promising' clinical trial results
Arrowhead Pharmaceuticals Inc. announced Feb. 5 that it had achieved “promising” interim results from early clinical trials for two of its drugs
NantHealth Stock Surges Again on News
Investors respond to promising AI test, software partnership
After months of relatively little news from billionaire Patrick Soon-Shiong’s Culver City-based network of health care businesses, the past few weeks have brought multiple developments that sent shares soaring.
RadNet Offering Cancer Treatment
Sets deal with Canadian medical device company
Sawtelle-based diagnostic imaging services company RadNet Inc. said it will explore entering the cancer treatment business.
EU OK’s Synedgen
Company wins patent for inflammation drug
Claremont-based biotech company Synedgen Inc. has been granted a European Union patent for its drug to treat GI inflammation related to cancer treatment.
Health Meets Wealth
Health Care: Arrowhead and Prospect Medical could give sector a shot in the arm
The Los Angeles health care market has seen a trend toward fewer but bigger deals in the last few years, and 2020 could bring more of the same.
Huntington Medical Research Institutes Awarded $1 Million Grant for Brain Research
Pasadena-based Huntington Medical Research Institutes has received a $1 million, three-year award from the W.M. Keck Foundation for brain research.
Ritter Pharmaceuticals to Be Acquired by Qualigen
Century City-based Ritter Pharmaceuticals Inc., which makes drugs to treat gastrointestinal diseases, is being acquired in a reverse merger with Carlsbad-based cancer therapy firm Qualigen Inc.
Prev Next